A Study of Oral E1018 in Healthy Adult Participants
- Conditions
- MalariaHealthy Participants
- Interventions
- Drug: E1018Drug: Placebo
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06854042
- Locations
- 🇺🇸
PPD Development, LP, Austin, Texas, United States
A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population
- Conditions
- Sleep Initiation and Maintenance DisordersPregnancy
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 861
- Registration Number
- NCT06744673
- Locations
- 🇺🇸
Eisai Trial Site #1, Nutley, New Jersey, United States
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT06602258
- Locations
- 🇺🇸
Advanced Memory Research Institute, Toms River, New Jersey, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
🇺🇸Sharp Neurocognitive Research Center at Sharp Mesa Vista Hospital, San Diego, California, United States
A Study of E2086 in Healthy Adult Participants
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT06481488
- Locations
- 🇺🇸
Parexel International, Glendale, California, United States
A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1
- Conditions
- Narcolepsy Type 1 (NT1)
- Interventions
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT06462404
- Locations
- 🇺🇸
SDS Clinical Trials, Santa Ana, California, United States
🇺🇸PharmaDev Clinical Research, Miami, Florida, United States
🇺🇸Sleep Practioners, LLC, Macon, Georgia, United States
A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer
- First Posted Date
- 2024-01-03
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT06188559
- Locations
- 🇺🇸
Community Cancer Center South, Indianapolis, Indiana, United States
🇺🇸University of Michigan Hospital, Ann Arbor, Michigan, United States
🇺🇸UCLA Center for East-West Medicine, Los Angeles, California, United States
A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT05745207
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05726851
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
- First Posted Date
- 2022-09-09
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT05533801
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
A Study to Assess the Safety and Tolerability of E2511 in Healthy Adult and Elderly Participants
- First Posted Date
- 2021-12-07
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT05147337
- Locations
- 🇺🇸
California Clinical Trials Medical Group, Glendale, California, United States